Old College Capital

University of Edinburgh fintech startup Aveni, a leading AI specialist in wealth management, financial advice and banking, today announced £12 million raised in its latest funding round.

A single-dose gene therapy could eliminate hard-to-treat brain tumours and prevent their recurrence. The treatment is based on research led by Professor Steve Pollard of the University of Edinburgh and spun out into biotech company Trogenix in 2023.

University of Edinburgh spinout, clean heat tech company Exergy3 has raised £10 million in seed funding to scale its proprietary technology addressing three of Europe’s most pressing challenges: industrial decarbonisation, grid balancing and energy security.

University of Edinburgh biotechnology spinout Pheno Therapeutics has announced its lead therapeutic candidate for MS has been cleared as an Investigational New Drug (IND) by the US Food and Drug Administration (FDA

The page describes working at Edinburgh Innovations, its ambitions and current vacancies.

Edinburgh Innovations is the University of Edinburgh’s commercialisation service, bringing research to industry and bringing ideas to life

Edinburgh Innovations connects organisations with research, expertise and facilities, and offers collaboration to develop ideas.

The page describes access to research expertise, technologies and facilities at the University of Edinburgh, as well as collaborative partnerships, contract research and consultancy across sectors.

Edinburgh Innovations works with investment, research and technology companies, research-active universities, SMEs (especially Scottish), and government/not-for-profit agencies looking to collaborate or invest in research and commercialisation activities within the University of Edinburgh.